Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients

BACKGROUND: Studies show that alemtuzumab, a potent lymphocyte-depleting agent, is well tolerated in pediatric renal transplantation. We report on the use of alemtuzumab induction in highly HLA sensitized (HS) pediatric kidney transplant patients. METHODS: Fifty pediatric renal transplants were perf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplantation
Autors principals: Kim, Irene K., Choi, Jua, Vo, Ashley A., Kang, Alexis, Patel, Mitasha, Toyoda, Mieko, Mirocha, James, Kamil, Elaine S., Cohen, J. Louis, Louie, Sabrina, Galera, Odette, Jordan, Stanley C., Puliyanda, Dechu P.
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer 2017
Matèries:
Original Clinical Science—General
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228615/
https://ncbi.nlm.nih.gov/pubmed/27495773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000001416
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars